Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Dunn School Student in Science Communication Competition Regional Final

General

Using a paper crane as a prop, Fodor lab DPhil student Bernadeta Dadonaite explained the potential of DNA origami technology to a capacity audience at the FameLab 2017 regional final at the Bullingdon bar and club in Oxford on 8 March.

FameLab helps communicate science to the general public in digestible three-minute competitive performances by students and researchers across the fields of science and engineering.  Running in over 25 countries worldwide the competition started at Cheltenham Science Festival in 20015.  Science Oxford runs the Oxford heats. 

Bernadeta was one of eight regional finalists grilled by a judging panel of experts from across Oxford: John Runions,  Reader in Cell and Molecular Biology at Oxford Brookes University; Jennifer Rogers, Vice President for External Affairs at the Royal Statistical Society and Director of Statistical Consultancy Services at Oxford University; and Alison Woollard, Oxford University Academic Champion for Public Engagement with Research. YouTube science vlogger Sally le Page hosted the event.

Read more (Sir William Dunn School of Pathology website)

Similar stories

Oxford vaccine reaches one billion doses released

The University of Oxford’s and our partners AstraZeneca have today announced that one billion doses of the ChAdOx1 nCov-19 coronavirus vaccine have been released, to more than 170 countries, marking a key milestone as part of the University and AstraZeneca’s joint vision to make the available to the world, on a not-for-profit basis for the world during the pandemic, and in perpetuity for low- and middle-income countries.

NCITA Publishes Comment Article in the British Journal of Cancer

Research programme tackling COVID-19 variants of concern receives funding boost

A gift from the Red Avenue Foundation will enable the expansion of a major research programme aimed at rapidly identifying and interrogating emerging COVID-19 variants.

Phase I trial begins of new vaccine against the Plague

Researchers at the University of Oxford today launched a Phase 1 trial to test a new vaccine against plague.

New therapeutic targets identified in the treatment of psoriatic arthritis

Researchers identify two inflammatory-driving proteins, osteopontin and CCL2, highly expressed in psoriatic arthritis joints.

Treatment choice for rotator cuff disorders could create efficiency and savings for the NHS

A trial that evaluated the clinical and cost effectiveness of physiotherapy treatments for rotator cuff disorders suggests cost savings can be made while maintaining positive patient outcomes.